Reviva Pharmaceuticals Holdings, Inc. Shares Outstanding (Cover Page)
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Shares Outstanding (Cover Page) of 13.11 million shares as of 2026-08-13, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-13: Entity Common Stock, Shares Outstanding 13.11M shares.
- 2026-05-13: Entity Common Stock, Shares Outstanding 13.11M shares.
- 2026-03-27: Entity Common Stock, Shares Outstanding 12.81M shares.
- 2025-11-11: Entity Common Stock, Shares Outstanding 115.06M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-13 | 13.11M shares 10-Q · filed 2026-08-12 |
| 2026-05-13 | 13.11M shares 10-Q · filed 2026-05-13 |
| 2026-03-27 | 12.81M shares 10-K · filed 2026-03-30 |
| 2025-11-11 | 115.06M shares 10-Q · filed 2025-11-13 |
| 2025-08-11 | 68.00M shares 10-Q · filed 2025-08-14 |
| 2025-05-12 | 46.74M shares 10-Q · filed 2025-05-15 |
| 2025-03-14 | 46.74M shares 10-K · filed 2025-04-03 |
| 2024-11-12 | 33.44M shares 10-Q · filed 2024-11-14 |
| 2024-08-12 | 29.82M shares 10-Q · filed 2024-08-14 |
| 2024-05-10 | 27.92M shares 10-Q · filed 2024-05-14 |
| 2024-03-31 | 27.92M shares 10-K · filed 2024-04-15 |
| 2023-11-09 | 22.65M shares 10-Q · filed 2023-11-14 |
| 2023-08-11 | 22.65M shares 10-Q · filed 2023-08-14 |
| 2023-05-11 | 20.63M shares 10-Q · filed 2023-05-15 |
| 2023-03-27 | 20.45M shares 10-K · filed 2023-03-30 |
| 2022-11-10 | 20.44M shares 10-Q · filed 2022-11-14 |
| 2022-08-12 | 18.13M shares 10-Q · filed 2022-08-15 |
| 2022-05-11 | 15.13M shares 10-Q · filed 2022-05-16 |
| 2022-03-10 | 15.13M shares 10-K · filed 2022-03-15 |
| 2021-11-12 | 13.98M shares 10-Q · filed 2021-11-15 |
| 2021-08-12 | 13.39M shares 10-Q · filed 2021-08-16 |
| 2021-05-13 | 9.23M shares 10-Q · filed 2021-05-17 |
| 2021-03-11 | 9.23M shares 10-K/A · filed 2021-05-07 |
| 2021-01-14 | 9.23M shares 10-Q · filed 2021-01-14 |
| 2020-10-14 | 5.12M shares 10-Q · filed 2020-10-14 |
| 2020-07-07 | 5.13M shares 10-Q · filed 2020-07-07 |
| 2020-05-01 | 7.67M shares 10-K · filed 2020-05-04 |
| 2020-01-10 | 8.27M shares 10-Q · filed 2020-01-10 |
| 2019-10-08 | 8.27M shares 10-Q · filed 2019-10-08 |
| 2019-07-03 | 8.27M shares 10-Q · filed 2019-07-03 |
| 2019-05-17 | 8.27M shares 10-K · filed 2019-05-22 |
| 2019-01-09 | 8.27M shares 10-Q · filed 2019-01-09 |
| 2018-10-11 | 8.27M shares 10-Q · filed 2018-10-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |